Precigen, Inc. SEC filings PGEN
Precigen, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jan 26, 2016. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Aug 19, 2025 | — |
| 424B5 | Prospectus supplement | Aug 8, 2024 | — |
| 424B5 | Prospectus supplement | Aug 6, 2024 | — |
| S-3 | Shelf registration | Dec 29, 2023 | — |
| S-8 | Employee stock plan registration | Jul 6, 2023 | — |
| 424B5 | Prospectus supplement | Jan 26, 2023 | — |
| 424B5 | Prospectus supplement | Jan 24, 2023 | — |
| 424B5 | Prospectus supplement | Aug 9, 2022 | — |
| 424B5 | Prospectus supplement | Jan 22, 2021 | — |
| 424B5 | Prospectus supplement | Jan 21, 2021 | — |
| S-3 | Shelf registration | Sep 30, 2020 | — |
| S-8 | Employee stock plan registration | Jun 22, 2020 | — |
| S-3 | Shelf registration | Jun 22, 2020 | — |
| S-8 | Employee stock plan registration | Aug 12, 2019 | — |
| S-8 | Employee stock plan registration | Aug 12, 2019 | — |
| 424B7 | Filing | Apr 12, 2019 | — |
| 424B7 | Filing | Nov 27, 2018 | — |
| S-8 | Employee stock plan registration | Aug 13, 2018 | — |
| 424B5 | Prospectus supplement | Jul 2, 2018 | — |
| 424B5 | Prospectus supplement | Jul 2, 2018 | — |
| FWP | Free writing prospectus | Jun 29, 2018 | — |
| FWP | Free writing prospectus | Jun 29, 2018 | — |
| FWP | Free writing prospectus | Jun 27, 2018 | — |
| 424B5 | Prospectus supplement | Jun 27, 2018 | — |
| 424B5 | Prospectus supplement | Jun 27, 2018 | — |
| 424B5 | Prospectus supplement | Jan 18, 2018 | — |
| 424B5 | Prospectus supplement | Jan 16, 2018 | — |
| S-3ASR | Automatic shelf registration | Sep 1, 2017 | — |
| S-8 | Employee stock plan registration | Aug 10, 2017 | — |
| 424B3 | Prospectus | May 12, 2017 | — |
| S-4/A | Filing | May 11, 2017 | — |
| S-4/A | Filing | Apr 21, 2017 | — |
| S-4 | Registration for a merger or exchange | Mar 17, 2017 | — |
| S-8 | Employee stock plan registration | Aug 10, 2016 | — |
Showing 34 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PGEN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- VA
- Headquarters
- Germantown, MD
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1356090
- Former names
- INTREXON CORP (until Jan 22, 2020)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.